15 Results for "

C4-2

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "C4-2" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-112197
CAS No.: 374703-78-3
Purity:  99.11%
Target:  

PKG

Research Areas:  

Cardiovascular Disease

PKG agent G1 targets C42 of PKG Iα. PKG agent G1 can couple to vasodilation and blood pressure lowering by a C42 PKG Iα-independent mechanism.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N2908
CAS No.: 4707-47-5
Synonyms: Methyl atrarate
Atraric acid (Methyl atrarate) is a specific androgen receptor (AR) antagonist with anti-inflammatory and anticancer effects. Atraric acid represses the expression of the endogenous prostate specific antigen gene in both LNCaP and C4-2 cells. Atraric acid can also inhibit the synthesis of NO and cytokine, and suppress the MAPK-NFκB signaling pathway. Atraric acid can be used to research prostate diseases and inflammatory diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12545
CAS No.: 85079-48-7
Synonyms: PbTx-3
Brevetoxin-3 (PbTx-3) is a potent allosteric voltage-gated Na + channel activator and has multiple active centers (A-ring lactone, C-42 of R side chain) . Brevetoxin-3 (PbTx-3) has a high affinity to site 5 of the voltage-sensitive Na + channels, inhibits the inactivation of Na + channels and prolongs the mean open time of these channels. Brevetoxin-3 (PbTx-3) repeated exposures can lead to prolonged airway hyperresponsiveness (AHR) and lung inflammation .
loading...
    loading...
Cat. No.: HY-122678
CAS No.: 354543-09-2
Purity:  97.13%
Target:  

Survivin Apoptosis

Research Areas:  

Cancer

LQZ-7F, a survivin dimerization inhibitor, induces spontaneous apoptosis and synergizes with Docetaxel in prostate cancer cells. LQZ-7F dose-dependently inhibits survival of both PC-3 and C4-2 cells with IC50s of 2.99 and 2.47 µM, respectively .
loading...
    loading...
Cat. No.: HY-168905
CAS No.: 2561494-76-4
Target:  

Calmodulin

Research Areas:  

Cancer

SGC-CAMKK2-1, a chemical probe, is the selective, inhibitor for calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) with an IC50 of 30 nM. SGC-CAMKK2-1 inhibits AMPK phosphorylation in cell C4-2 with an IC50 of 1.6 μM .
loading...
    loading...
Cat. No.: HY-14165
CAS No.: 128253-31-6
Purity:  99.48%
Synonyms: BAY X 1005; DG-031
Veliflapon (BAY X 1005; DG-031) is an orally active and selective 5-lipoxygenase activating protein (FLAP) inhibitor . Veliflapon inhibits the synthesis of the leukotrienes B4 and C4 .
loading...
    loading...
Cat. No.: HY-175017
Target:  

Survivin

Research Areas:  

Cancer

Survivin-IN-2 is a survivin inhibitor. Survivin-IN-2 shows cytotoxicity in cells with IC50s of 0.53 μM (C4-2 cells) and 1.06 μM (PC-3 cells). Survivin-IN-2 effectively suppresses xenograft tumor growth without apparent toxicity and eliminates survivin in the tumors. Survivin-IN-2 can be used for the study of prostate cancer .
loading...
    loading...
Cat. No.: HY-161872
Target:  

Autophagy p62

Research Areas:  

Cancer

LC3in-C42 is a cell-active LC3A/B and autophagy covalent inhibitor. LC3in-C42 selectively inhibits the binding of P62 to LC3A/B in vitro and at the cellular level like D5 and can function on a lower concentration .
loading...
    loading...
Cat. No.: HY-124585
CAS No.: 2222565-19-5
Research Areas:  

Cancer

Y08060 is a selective BET inhibitor. Y08060 inhibits the viability of C4-2B and LNCaP cell lines with IC50 values of 3.23 and 4.41 μM. Y08060 can suppress colony formation as well as AR expression in prostate cancer cell line. Y08060 can be studied in prostate cancer research .
loading...
    loading...
Cat. No.: HY-121588
CAS No.: 851688-13-6
Target:  

Adrenergic Receptor

Research Areas:  

Cancer

IMTPPE is an inhibitor of the androgen receptor (AR) in C4-2 prostate cancer cells, inhibiting its transcriptional activity and protein levels. IMTPPE inhibited the proliferation of AR-positive prostate cancer cells but had no effect on AR-negative prostate cancer cells. IMTPPE also inhibited the growth of enzalutamide-resistant 22Rv1 xenograft tumors .
loading...
    loading...
Cat. No.: HY-N2908R
CAS No.: 4707-47-5
Synonyms: Methyl atrarate (Standard)
Atraric acid (Standard) is the analytical standard of Atraric acid. This product is intended for research and analytical applications. Atraric acid (Methyl atrarate) is a specific androgen receptor (AR) antagonist with anti-inflammatory and anticancer effects. Atraric acid represses the expression of the endogenous prostate specific antigen gene in both LNCaP and C4-2 cells. Atraric acid can also inhibit the synthesis of NO and cytokine, and suppress the MAPK-NFκB signaling pathway. Atraric acid can be used to research prostate diseases and inflammatory diseases[1][2].
loading...
    loading...
Cat. No.: HY-RS25071
Research Areas:  

Others

C4b Rat Pre-designed siRNA Set A contains three designed siRNAs for C4b gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS02389
Research Areas:  

Others

CDK5RAP1 Human Pre-designed siRNA Set A contains three designed siRNAs for CDK5RAP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-142772
CAS No.: 2688745-47-1
Y08284 is a potent, selective, oral active CBP bromodomain inhibitor with an IC50 of 4.21 nM. Y08284 suppresses the proliferation of prostate cancer cell lines LNCaP, C4-2B, and 22Rv1. Antitumor activity .
loading...
    loading...
Cat. No.: HY-169349
CAS No.: 6605-17-0
Target:  

Androgen Receptor

Research Areas:  

Cancer

Androgen receptor antagonist 12 (Compound EF2) is an orally active Androgen receptor (AR) antagonist (IC50: 0.30 μM). Androgen receptor antagonist 12 inhibits transcriptional activity of variant AR mutants and and the proliferation of AR-positive PCa cell lines. Androgen receptor antagonist 12 blocks AR nuclear translocation. Androgen receptor antagonist 12 inhibits tumor growth in a C4-2B xenograft mouse model. Androgen receptor antagonist 12 can be used for prostate cancer (PCa) research .
loading...
    loading...
  • 1